BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6602167)

  • 1. Induction of cytotoxic T cell function requires sequential action of three different lymphokines.
    Männel DN; Falk W; Dröge W
    J Immunol; 1983 Jun; 130(6):2508-10. PubMed ID: 6602167
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.
    Falk W; Männel DN; Dröge W
    J Immunol; 1983 May; 130(5):2214-8. PubMed ID: 6220085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 2 is not sufficient for the continuous growth of cloned NK-like cytotoxic cell lines.
    Olabuenaga SE; Brooks CG; Gillis S; Henney CS
    J Immunol; 1983 Nov; 131(5):2386-91. PubMed ID: 6605387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of lymphokines in the generation of cytotoxic T lymphocytes].
    Kasakura S
    Rinsho Ketsueki; 1984 Apr; 25(4):479-87. PubMed ID: 6236311
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses.
    Shaw J; Caplan B; Paetkau V; Pilarski LM; Delovitch TL; McKenzie IF
    J Immunol; 1980 May; 124(5):2231-9. PubMed ID: 6965968
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of cytokines in T and B cell mediated immunity.
    Gately MK; Jenson JC; Benjamin WR
    Concepts Immunopathol; 1986; 3():74-108. PubMed ID: 3297329
    [No Abstract]   [Full Text] [Related]  

  • 7. Macrophage-independent activation of helper T cells. I. Production of Interleukin 2.
    Farrar JJ; Mizel SB; Fuller-Farrar J; Farrar WL; Hilfiker ML
    J Immunol; 1980 Aug; 125(2):793-8. PubMed ID: 6967089
    [No Abstract]   [Full Text] [Related]  

  • 8. Heterogeneity of lymphokine production by murine T-lymphocyte clones.
    MacDonald HR; Glasebrook AL; Kelso A; Zubler RH
    Ann Immunol (Paris); 1982; 133D(2):171-8. PubMed ID: 6819809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of T cell growth stimulating factors in T cell triggering.
    Grönvik KO; Andersson J
    Immunol Rev; 1980; 51():35-59. PubMed ID: 6448799
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulatory counteraction to IL-2 activity.
    Kramer MD; Koszinowski UH
    Lymphokine Res; 1983; 2(3):77-82. PubMed ID: 6235407
    [No Abstract]   [Full Text] [Related]  

  • 11. Three different signals are required for the induction of cytolytic T lymphocytes from resting precursors.
    Kanagawa O
    J Immunol; 1983 Aug; 131(2):606-10. PubMed ID: 6602842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
    Ting CC; Hargrove ME
    J Immunol; 1983 Oct; 131(4):1734-41. PubMed ID: 6604751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction of mouse CD8+ suppressor effector T cell clones from cytotoxic T cell clones by cytokine production and CD45 isoforms.
    Inoue T; Asano Y; Matsuoka S; Furutani-Seiki M; Aizawa S; Nishimura H; Shirai T; Tada T
    J Immunol; 1993 Mar; 150(6):2121-8. PubMed ID: 8450205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonspecific suppression of in vitro generation of cytotoxic lymphocytes by allogeneic and xenogeneic embryonic tissues.
    Croy BA; Rossant J; Clark DA; Wegmann TG
    Transplantation; 1983 Jun; 35(6):627-9. PubMed ID: 6603036
    [No Abstract]   [Full Text] [Related]  

  • 16. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection.
    Li XC; Roy-Chaudhury P; Hancock WW; Manfro R; Zand MS; Li Y; Zheng XX; Nickerson PW; Steiger J; Malek TR; Strom TB
    J Immunol; 1998 Jul; 161(2):890-6. PubMed ID: 9670967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes.
    Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A
    Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble factor mediated T cell, B cell, and macrophage interactions in the regulation of the immune response in man.
    Warrington RJ; Wilkins JA
    Lymphokine Res; 1984; 3(3):137-44. PubMed ID: 6611468
    [No Abstract]   [Full Text] [Related]  

  • 19. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
    Seo N; Tokura Y; Takigawa M; Egawa K
    J Immunol; 1999 Jul; 163(1):242-9. PubMed ID: 10384122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
    Bobbio SA; Wood ML; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.